Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Boehringer Ingelheim
Boehringer Ingelheim
AstraZeneca follows rival Boehringer in capping out-of-pocket costs for inhalers
Reuters
Mon, 03/18/24 - 11:05 am
AstraZeneca
inhalers
drug pricing
Boehringer Ingelheim
Airsupra
Bevespi Aerosphere
Breztri Aerosphere
COPD
Asgard Gets $32M Series A Backing from J&J, Novo and Boehringer
BioSpace
Sun, 03/17/24 - 09:25 pm
Asgard Therapeutics
JNJ
Novo Nordisk
Boehringer Ingelheim
funding
immuno-oncology
Boehringer licenses Sosei schizophrenia drugs in €755m deal
Pharmaphorum
Mon, 03/11/24 - 11:40 am
Boehringer Ingelheim
schizophrenia
Sosei
Boehringer to cap out-of-pocket inhaler cost at $35 per month
Reuters
Thu, 03/7/24 - 11:08 am
Boehringer Ingelheim
drug pricing
Atrovent
Combivent Respimat
Spiriva HandiHale
COPD
Boehringer’s survodutide shows monster MASH potential
Pharmaphorum
Mon, 02/26/24 - 10:36 am
Boehringer Ingelheim
weight loss
MASH
NASH
survodutide
Notable Labs hopes for success with Boehringer’s failed AML drug
Clinical Trials Arena
Fri, 02/23/24 - 10:35 am
Notable Labs
Boehringer Ingelheim
AML
volasertib
artificial intelligence
Boehringer Ingelheim pledges €120M to expand Greek plant, add capacity for Jardiance
Fierce Pharma
Fri, 01/12/24 - 09:55 am
Boehringer Ingelheim
drug manufacturing
Greece
Jardiance
Most extensive cirrhosis £30M study funded by Boehringer Ingelheim
Outsourcing Pharma
Mon, 01/8/24 - 11:26 am
Boehringer Ingelheim
liver cirrhosis
funding
Beleaguered Theravance logs head-to-head trial loss for Yupelri against Boehringer's Spiriva
Fierce Pharma
Sun, 01/7/24 - 04:07 pm
Theravance
Yupelri
COPD
Boehringer Ingelheim
Spiriva
Boehringer bets $2B in biobucks to unlock siRNA targets for NASH treatments
Fierce Biotech
Wed, 01/3/24 - 09:40 am
Boehringer Ingelheim
biobucks
NASH
siRNA
Suzhou Ribo
Ribocure
3 standout digital innovations in pharma this year
Pharma Voice
Mon, 12/4/23 - 09:44 am
IDEA Pharma
innovation
digital pharma
AstraZeneca
Roche
Boehringer Ingelheim
Boehringer Ingelheim to collaborate with Phenomic AI on stroma-rich cancers
Medical Marketing and Media
Wed, 11/29/23 - 11:38 pm
Boehringer Ingelheim
artificial intelligence
Phenomic AI
stroma-rich cancers
Boehringer plugs in IBM-trained AI model to boost antibody drug discovery efforts
Fierce Biotech
Tue, 11/28/23 - 10:18 am
Boehringer Ingelheim
artificial intelligence
IBM
machine learnings
drug discovery
Skyrizi goes sky-high in October among Rx, OTC pharma brands
Medical Marketing and Media
Sun, 11/12/23 - 09:19 pm
Boehringer Ingelheim
AbbVie
Skyrizi
DTC advertising
pharma advertising
Boehringer clears blues to go green, unveiling new corporate branding to convey 'unwavering optimism'
Fierce Pharma
Thu, 11/9/23 - 09:51 am
Boehringer Ingelheim
branding
AbbVie, AstraZeneca, Boehringer and more face FTC's ire for 'improper' patent listings
Fierce Pharma
Tue, 11/7/23 - 11:08 pm
FTC
Orange Book
patents
AbbVie
AstraZeneca
Boehringer Ingelheim
EU Commission fines pharma companies for price fixing
Reuters
Mon, 10/23/23 - 09:36 am
Europe
API
price fixing
antitrust
Alkaloids
Linnea
Boehringer Ingelheim
Transo-Pharm
Chasing Boehringer, Anaptys hits goal in pivotal rare skin disease trial, plans out-licensing deal
Fierce Biotech
Mon, 10/9/23 - 10:11 am
AnaptysBio
generalized pustular psoriasis
clinical trials
imsidolimab
Boehringer Ingelheim
Boehringer moves obesity therapy into phase 3
Pharmaphorum
Fri, 10/6/23 - 10:01 am
Boehringer Ingelheim
Zealand Pharma
clinical trials
obesity
survodutide
Boehringer Ingelheim embraces dual-pricing tactic with launch of unbranded Humira biosimilar
Fierce Pharma
Wed, 10/4/23 - 11:21 am
Boehringer Ingelheim
Cyltezo
biosimilars
Humira
drug pricing
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »